# Pharmacokinetics of Intranasal Ketorolac in Children

> **NCT02297906** · PHASE1 · TERMINATED · sponsor: **Columbia University** · enrollment: 18 (estimated)

## Conditions studied

- Evaluating Pharmacokinetics of Intranasal Ketorolac
- Pain

## Interventions

- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT02297906
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2017-11-29
- **Final completion:** 2017-11-29
- **Target enrollment:** 18 (ESTIMATED)
- **Why stopped:** Enrolment issues
- **Last updated:** 2019-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02297906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02297906, "Pharmacokinetics of Intranasal Ketorolac in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02297906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*